Chemfab Alkalis Ltd vs Eiko Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Chemfab Alkalis Ltd is ₹ 356.85 as of 20 Mar 15:30 . The P/E Ratio of Chemfab Alkalis Ltd changed from 12.3 on March 2022 to 35 on March 2024 . This represents a CAGR of 41.71% over 3 yearsThe P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years The Market Cap of Chemfab Alkalis Ltd changed from ₹ 1013 crore on March 2025 to ₹ 922.45 crore on March 2024 . This represents a CAGR of -1.87% over 5 yearsThe Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of Chemfab Alkalis Ltd for the Dec '25 is ₹ 70.91 crore as compare to the Sep '25 revenue of ₹ 78.32 crore. This represent the decline of -9.46% The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The ebitda of Chemfab Alkalis Ltd for the Dec '25 is ₹ 4.71 crore as compare to the Sep '25 ebitda of ₹ 7.22 crore. This represent the decline of -34.76% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The net profit of Chemfab Alkalis Ltd changed from ₹ 0.9 crore to ₹ -4.45 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The Dividend Payout of Chemfab Alkalis Ltd changed from 6.12 % on March 2022 to 11.79 % on March 2025 . This represents a CAGR of 17.81% over 4 yearsThe Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Chemfab Alkalis Ltd

Chemfab Alkalis Limited, formerly known as Teamec Chlorates Limited was incorporated on 06 May, 2009.
The name of the Company was changed from Teamec Chlorates Limited to Chemfab Alkalis Limited on July 21, 2017, vide Revised Certi?cate of Incorporation issued by the Registrar of Companies pursuant to the Scheme of Amalgamation dated 30 March 2017.
The Company is a manufacturer of caustic soda lye, ?akes, liquid chlorine, hydrogen gas, PVCO Pipes and other products.
The Company is engaged in manufacturing of basic inorganic chemicals and PVCO Pipes. In 1985, Company was first to install the Monopolar Electrolysers from M/s.
Chlorine Engineers Corporation, Japan (CEC).

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

FAQs for the comparison of Chemfab Alkalis Ltd and Eiko Lifesciences Ltd

Which company has a larger market capitalization, Chemfab Alkalis Ltd or Eiko Lifesciences Ltd?

Market cap of Chemfab Alkalis Ltd is 512 Cr while Market cap of Eiko Lifesciences Ltd is 75 Cr

What are the key factors driving the stock performance of Chemfab Alkalis Ltd and Eiko Lifesciences Ltd?

The stock performance of Chemfab Alkalis Ltd and Eiko Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chemfab Alkalis Ltd and Eiko Lifesciences Ltd?

As of March 22, 2026, the Chemfab Alkalis Ltd stock price is INR ₹356.85. On the other hand, Eiko Lifesciences Ltd stock price is INR ₹52.4.

How do dividend payouts of Chemfab Alkalis Ltd and Eiko Lifesciences Ltd compare?

To compare the dividend payouts of Chemfab Alkalis Ltd and Eiko Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.